Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
dc.contributor.author | Rajendranath, R | |
dc.contributor.author | Balasubramaniyum, V K K | |
dc.contributor.author | Vijayakumar, V | |
dc.contributor.author | Ganesan, P | |
dc.contributor.author | Tenali, G S | |
dc.date.accessioned | 2016-02-11T10:33:06Z | |
dc.date.available | 2016-02-11T10:33:06Z | |
dc.date.issued | 2014-10 | |
dc.description.abstract | BACKGROUND: Outcome of febrile neutropenia (FN) in acute leukemia patients undergoing intensive chemotherapy from India is scanty. MATERIALS AND METHODS: A prospective, observational, single institutional study was conducted to evaluate the clinical features, microbiological aspects, risk factors influencing the outcome of high risk FN during intensive therapy in acute leukemia. RESULTS: Among 115 febrile episodes, though 94 (81.7%) had indwelling central venous catheter (CVC) at the time of diagnosis of FN, infective foci clinically were identified in 70.4% of episodes, with lung as the major site (25.2%) followed by CVC (17.4%). Microbiological documentation was possible in 33% (n = 40) episodes. Gram‑negative bacteria isolates were 58.3% and Gram‑positive isolates were 41.7% of which Pseudomonas was the predominant Gram‑negative and Staphylococcus aureus was the most common Gram‑positive isolate. Piperacillin‑tazobactam + amikacin were used as first line antibiotic in 93% episodes and second line antibiotics were necessary in 73% episodes. Granulocyte colony stimulating factor was used in 60.9% episodes of high risk FN mostly in acute myeloid leukemia consolidation patients. Eighteen episodes (15.7%) were assigned to have invasive fungal disease. Eleven (9.6%) out of 115 high risk FN had a fatal outcome. Presence of pulmonary infection predicted for fatal outcome (P = 0.02). CONCLUSION: This study reports the outcome of high risk FN in patients with acute leukemia undergoing intensive chemotherapy. Gram‑negative isolates are highly sensitive to piperacillin‑tazobactum and hence in a cost restraint scenario, carbapenems needs to be judiciously used. Focus of Infection in lungs during FN predicted higher fatal outcomes. | en_US |
dc.identifier.citation | Rajendranath R, Balasubramaniyum V K K, Vijayakumar V, Ganesan P, Tenali G S. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India. Indian Journal of Cancer. 2014 Oct-Dec; 51(4): 481-486. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/172474 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.indianjcancer.com/article.asp?issn=0019-509X;year=2014;volume=51;issue=4;spage=481;epage=486;aulast=Rajendranath | en_US |
dc.subject | Acute leukemia | en_US |
dc.subject | catheter related infections | en_US |
dc.subject | febrile neutropenia | en_US |
dc.subject | high risk | en_US |
dc.title | Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijc2014v51n4p481.pdf
- Size:
- 554.89 KB
- Format:
- Adobe Portable Document Format
- Description:
- Original article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: